• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

NeRRe Therapeutics

edit

NeRRe Therapeutics Ltd. operates as a biotechnology company that develops clinical and pre-clinical neurokinin receptor antagonists. The company was founded in 2012 and is based in Stevenage, United Kingdom.

Recent Milestones

edit

• 
  NeRRe Therapeutics received $18.4M in Series A funding. (12/19/12)
  Posted 12/20/12 at 6:25am via biospace.com

Videos

Screenshots

edit

Sources

1. Ex-GlaxoSmithKline (GSK) Neuroscientists Nab $18.4 Million Series A Financing for New Co. NeRRe Therapeutics Ltd (biospace.com) [edit]